US 2014/0271490 A1Published application

Bacteria-targeted magnetic resonance contrast agents

AssigneeNorthwestern University

InventorsLauren M. Matosziuk, Allison S. Harney, Keith W. MacRenaris, Thomas J. Meade

Life of this patent

Estimating the term…

Abstract

The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.

Claims14

Dependent claims

A composition comprising a contrast agent comprising a metal chelate conjugated to at least two Zn-dipicolylamine groups.

Dependencies are inferred from the claim text.

Facts

Application: 14/198,853Filed 6 Mar 2014
Priority: 13 Mar 2013
Published: 18 Sep 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 49/085
Characterised by the carrier: conjugated systems
A61K 49/106
The carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals: the complex-forming compound being…
C07F 5/003
Compounds containing elements of Groups 3 or 13 of the Periodic Table: without C-Metal linkages
C12Q 1/10
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a…

Family

Application61/779,115Us provisional application · filed 13 Mar 2013
US 9,566,355 B2Related patent
US 2014/0271490 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results